Characterization and analysis of the proximal Janus kinase 3 promoter

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6057-6064

  Aringer, Martin ^a,b   Hofmann, Sigrun R ^a   Frucht, David M ^a   Chen, Min ^a   Centola, Michael ^a   Morinobu, Akio ^a   Visconti, Roberta ^a   Kastner, Daniel L ^a   Smolen, Josef S ^b   O'Shea, John J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; HISTONE; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 9 RECEPTOR; JANUS KINASE; JANUS KINASE 3; MESSENGER RNA; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ACETYLATION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME REGULATION; GENE ACTIVITY; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INTRON; LYMPHOID TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

EID: 0037605818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6057     Document Type: Article

References (55)

1. Ihle, J. N., W. Thierfelder, S. Teglund, D. Stravapodis, D. Wang, J. Feng, and E. Parganas. 1998. Signaling by the cytokine receptor superfamily. Ann. NY Acad. Sci. 865:1.
2. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1.
3. Baird, A. M., D. C. Thomis, and L. J. Berg. 1998. T cell development and activation in Jak3-deficient mice. J. Leukocyte Biol. 63:669.
4. Aringer, M., A. Cheng, J. W. Nelson, M. Chen, C. Sudarshan, Y. J. Zhou, and J. J. O'Shea. 1999. Janus kinases and their role in growth and disease. Life Sci. 64:2173.
5. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1.
6. Chen, M., A. Cheng, Y. Q. Chen. A. Hymel, E. P. Hanson, L. Kimmel, Y. Minami, T. Taniguchi, P. S. Changelian, and J. J. O'Shea. 1997. The amino terminus of JAK3 is necessary and sufficient for binding to the common γ chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 94:6910.
7. Cacalano, N. A., T. S. Migone, F. Bazan, E. P. Hanson, M. Chen, F. Candotti, J. J. O'Shea, and J. A. Johnston. 1999. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J. 18:1549.
8. Buckley, R. H., R. I. Schiff, S. E. Schiff, M. L. Markert, L. W. Williams, T. O. Harville, J. L. Roberts, and J. M. Puck. 1997. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J. Pediatr. 130:378.
9. Candotti, F., J. J. O'Shea, and A. Villa. 1998. Severe combined immune deficiencies due to defects of the common γ chain-JAK3 signaling pathway. Springer Semin. Immunopathol. 19:401.
10. Schumacher, R. F., P. Mella, R. Badolato, M. Fiorini, G. Savoldi, S. Giliani, A. Villa, F. Candotti, A. Tampalini, J. J. O'Shea, et al. 2000. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism. Hum. Genet. 106:73.
11. Brugnoni, D., L. D. Notarangelo, A. Sottini, P. Airo, M. Pennacchio, E. Mazzolari, S. Signorini, F. Candotti, A. Villa, P. Mella, et al. 1998. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase. Blood 91:949.
12. Thomis, D. C., C. B. Gurniak, E. Tivol, A. H. Sharpe, and L. J. Berg. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794.
13. Park, S. Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771.
14. Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519.
15. + T cells, but not natural killer cells. J. Exp. Med 184:289.
16. Maraskovsky, E., M. Teepe, P. J. Morrissey, S. Braddy, R. E. Miller, D. H. Lynch, and J. J. Peschon. 1996. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J. Immunol. 157:5315.
17. Candeias, S., J. J. Peschon, K. Muegge, and S. K. Durum. 1997. Defective T-cell receptor γ gene rearrangement in interleukin-7 receptor knockout mice. Immunol. Lett. 57:9.
18. + severe combined immunodeficiency. Nat. Genet. 20:394.
19. Baird, A. M., J. A. Lucas, and L. J. Berg. 2000. A profound deficiency in thymic progenitor cells in mice lacking Jak3. J. Immunol. 165:3680.
20. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669.
21. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
22. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
23. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, and H. Griesser. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
24. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse III, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630.
25. Suto, A., H. Nakajima, K. Hirose, K. Suzuki, S. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D. C. Foster, and I. Iwamoto. 2002. Interleukin 21 prevents antigeninduced IgE production by inhibiting germ line Cε transcription of IL-4-stimulated B cells. Blood 100:4565.
26. Kawamura, M., D. W. McVicar, J. A. Johnston, T. B. Blake, Y. Q. Chen, B. K. Lal, A. R. Lloyd, D. J. Kelvin, J. E. Staples, and J. R. Ortaldo. 1994. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc. Natl. Acad. Sci. USA 91:6374.
27. Takahashi, T., and T. Shirasawa. 1994. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. FEBS Lett. 342:124.
28. Gurniak, C. B., and L. J. Berg. 1996. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood 87:3151.
29. Safford, M. G., M. Levenstein, E. Tsifrina, S. Amin, A. L. Hawkins, C. A. Griffin, C. I. Civin, and D. Small. 1997. JAK3: expression and mapping to chromosome 19p12-13.1. Exp. Hematol. 25:374.
30. Takahashi, T., T. Shirasawa, K. Miyake, Y. Yahagi, N. Maruyama, N. Kasahara, T. Kawamura, O. Matsumura, T. Mitarai, and O. Sakai. 1995. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem. Biophys. Res. Commun. 209:218.
31. Takahashi, T., T. Shirasawa, K. Miyake, Y. Yahagi, O. Matsumura, A. Abe, Y. Natori, H. Yamabe, Y. Utsunomiya, N. Maruyama, et al. 1996. Jak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients. Clin. Exp. Immunol. 104:517.
32. Verbsky, J. W., E. A. Bach, Y. F. Fang, L. Yang, D. A. Randolph, and L. E. Fields. 1996. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J. Biol. Chem. 271:13976.
33. Villa, A., M. Sironi, P. Macchi, C. Matteucci, L. D. Notarangelo, P. Vezzoni, and A. Mantovani. 1996. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene. Blood 88:817.
34. Sofer, L., D. Kampa, and J. Burnside. 1998. Molecular cloning of a chicken JAK homolog from activated T cells. Gene 215:29.
35. Tortolani, P. J., B. K. Lal, A. Riva, J. A. Johnston, Y. Q. Chen, G. H. Reaman, M. Beckwith, D. Longo, J. R. Ortaldo, and K. Bhatia. 1995. Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J. Immunol. 155:5220.
36. Musso, T., J. A. Johnston, D. Linnekin, L. Varesio, T. K. Rowe, J. J. O'Shea, and D. W. McVicar. 1995. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J. Exp. Med. 181:1425.
37. Rane, S. G., and E. P. Reddy. 1994. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 9:2415.
38. McDermott, M. F., I. Aksentijevich, J. Galon, E. M. McDermott, B. W. Ogunkolade, M. Centola, E. Mansfield, M. Gadina, L. Karenko, T. Pettersson, et al. 1999. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133.
39. Wingender, E., P. Dietze, H. Karas, and R. Knuppel. 1996. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res. 24:238.
40. Chen, M., A. Cheng, F. Candotti, Y. J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea. 2000. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20:947.
41. Lai, K. S., Y. Jin, D. K. Graham, B. A. Witthuhn, J. N. Ihle, and E. T. Liu. 1995. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. J. Biol. Chem. 270:25028.
42. Jang, W., H. C. Chen, H. Sicotte, and G. D. Schuler. 1999. Making effective use of human genomic sequence data. Trends Genet. 15:284.
43. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. Matnd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878.
44. Gurniak, C. B., D. C. Thomis, and L. J. Berg. 1997. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3. DNA Cell Biol. 16:85.
45. Leu, J. H., S. J. Yan, T. F. Lee, C. M. Chou, S. T. Chen, P. P. Hwang, C. K. Chou, and C. J. Huang. 2000. Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes. DNA Cell Biol. 19:431.
46. Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell. Biol. 2:827.
47. Li, R., H. Pei, and D. K. Watson. 2000. Regulation of Ets function by protein-protein interactions. Oncogene 19:6514.
48. Bories, J. C., D. M. Willerford, D. Grevin, L. Davidson, A. Camus, P. Martin, D. Stehelin, and F. W. Alt. 1995. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377:635.
49. Muthusamy, N., K. Barton, and J. M. Leiden. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377:639.
50. Barton, K., N. Muthusamy, C. Fischer, C. N. Ting, T. L. Walunas, L. L. Lanier, and J. M. Leiden. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:5553.
51. Bassuk, A. G., and J. M. Leiden. 1995. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223.
52. Wasylyk, B., C. Wasylyk, P. Flores, A. Begue, D. Leprince, and D. Stehelin. 1990. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346:191.
53. Foletta, V. C., D. H. Segal, and D. R. Cohen. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol. 63:139.
54. Yu, C. L., and S. J. Burakoff. 1997. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J. Biol. Chem. 272:14017.
55. Ungureanu, D., P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:3316.